A Potential Link to Recurrent Pregnancy Loss: Monoclonal Anti-PF4 Antibodies’ Role
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
”Monoclonal Anti –Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss.”
Read the full article here.
In a newly published article ”Monoclonal Anti–Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss ” in The New England Journal of Medicine (NEJM) by Natalie R. Bavli et al., the role of monoclonal anti-platelet factor 4 antibodies in cases of recurring misscarriage is discussed.
Emerging evidence suggests that monoclonal anti–platelet factor 4 (PF4) antibodies may play a role in persistent thrombotic thrombocytopenia.
In a recent report, two patients with monoclonal anti-PF4 antibody-mediated thrombosis also experienced chronic intermittent thrombocytopenia and recurrent first-trimester pregnancy losses.
This combination of clinical findings points to a potential association between these antibodies and obstetrical complications, including recurrent pregnancy loss.
Further research in larger cohorts is needed to better understand this possible connection and its implications for maternal health.
More on the latest scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Sep 6, 2025, 14:04Chokri Ben Lamine – VTE Prophylaxis in Pregnancy (ASH 2018 Guidelines)
-
Sep 6, 2025, 13:48The Body Explained on Blood Clotting Pathways
-
Sep 5, 2025, 14:06Thrombosis Update: VTE Death Rate 3X Higher in Los Angeles Jails Than General Population
-
Sep 5, 2025, 10:59New Study Featured by Rare Disease Advisor Reveals Quality-of-Life Challenges in Hemophilia
-
Sep 4, 2025, 22:00Shivani Modi Highlights SOHO 2025 Study Linking Elevated WBC Counts to Increased Thrombosis Risk
-
Sep 6, 2025, 16:43Khaled Musallam: de-LIGHT Study on Use of Lifetime Anemia and Iron Control Index (LAICI) in Thalassemia Treatment
-
Sep 6, 2025, 15:06Managing Gynecologic Bleeding in Anticoagulated Patients: Toolkit Co-Authored by Divyaswathi Citla Sridhar
-
Sep 6, 2025, 14:30Mattia Galli on Whether Reduction in MACE Really Depicts Situation in Spontaneous MI or Death post-PCI
-
Sep 6, 2025, 13:55Patrick Cieran Gallogly and Colleagues on Atypical Symptoms in TIA and Minor Stroke
-
Sep 6, 2025, 13:37Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 2, 2025, 12:51Treatment of Deep Brain AVMs Tied to Increased Hemorrhagic Stroke Risk
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Sep 6, 2025, 14:09Erin VanDyke: Shifting Attention Upstream in VTE Care Through NBCA Centers of Excellence
-
Sep 6, 2025, 12:02Caitlin Raymond on Kairos in Medicine: How Curiosity Sustains Physicians and Prevents Burnout
-
Sep 5, 2025, 14:12EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
-
Sep 5, 2025, 10:58Côme Bommier Recommends CRTH for Clinical Trial Training and Career Growth in Hematology
-
Sep 5, 2025, 10:55EHC This Way Webinar: Enhancing Joint Health Through Exercise - 8 Sept